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Abstract
The role of T cells in innate immunity is not well defined. In this report, we show that a subset of human peripheral blood
CD4
+ T cells responds to IL-12 plus IL-18, but not to IL-12 or IL-18 alone, by producing IFN-c in the absence of any antigenic
stimulation or cell proliferation. Intracellular staining reveals a small percentage of resting CD4
+ T cells (0.5 to 1.5%) capable
of producing IFN-c in response to IL-12 plus IL-18. Interestingly, both naı ¨ve (CD45RA
+) and memory (CD45RO
+) CD4
+
populations were responsive to IL-12 plus IL-18 stimulation in producing IFN-c. The expression of IFN-cinduced by IL-12 and
IL-18 is sensitive to rapamycin and SB203580, indicating the possible involvement of mTOR and p38 MAP kinase,
respectively, in this synergistic pathway. While p38MAP kinase is involved in transcription, mTOR is involved in message
stabilization. We have also shown that NFkB family member, cRel, but not GADD45b and GADD45c, plays an important role
in IL-12 plus IL-18-induced IFN-c transcription. Thus, the present study suggests that naı ¨ve CD4
+ T cells may participate in
innate immunity or amplify adaptive immune responses through cytokine-induced antigen-independent cytokine
production.
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Introduction
Interferon c (IFN-c) plays an important role in host defense.
The major sources of this cytokine are T cells and natural killer
(NK) cells [1]. In T helper type 1 (Th1) cells, at least two distinct
receptor-mediated pathways can induce IFN-c production [2,3].
Differentiated Th1 cells can produce IFN-c upon T cell receptor
(TCR) engagement, which is enhanced by co-stimulation through
anti-CD28 and is sensitive to cyclosporin A [2,3]. This TCR-
induced IFN-c production is antigen-specific, associated with T
cell proliferation, and a component of the adaptive immune
response. Also, differentiated murine Th1 cells that have acquired
expression of both interleukin 12 (IL-12) and IL-18 receptors can
directly produce IFN-c in response to IL-12 and IL-18 in the
absence of TCR engagement; both act synergistically to enhance
IFN-c production through pathways that are insensitive to
cyclosporin A [2,3]. This TCR-independent IFN-c production is
antigen-nonspecific and a component of the innate immune
response.
The synergistic effect of IL-12 and IL-18 on IFN-c production
is not fully understood. One of the mechanisms that could
partially explain the synergism of IL-12 and IL-18 for IFN-c
production is the reciprocal up-regulation of their receptors in
responding cells [4,5,6]. Another mechanism is simultaneous
activation and cooperation of STAT4, GADD45b,N F - kB, and/
or AP-1 that induce IFN-c transcription [3,7,8,9,10,11]. In this
report, we demonstrate that human peripheral blood CD4
+ T
cells produce IFN-c after treatment with IL-12 and IL-18, but
not with IL-12 or IL-18 treatment alone, and the IFN-c
production is sensitive to rapamycin and SB203580, indicating
the possible involvement of mTOR and p38 MAP kinase.
Interestingly, naı ¨ve and memory CD4
+ T cells are responsible for
IFN-c production. Our results suggest that T cells may play a
critical role in innate immunity through cytokine-induced
antigen-independent cytokine production.
Materials and Methods
Cells and tissue cultures
Peripheral blood mononuclear cells (PBMC) collected from
healthy donors were isolated by Ficoll-Paque density gradient
centrifugation. Collection of blood from donors (who provided
informed written consent) were done according to the protocol
(#2003-054) approved by the NIA review board. CD4
+ T cells
were purified from PBMC using MACS CD4
+ T cells isolation kit
II (Miltenyi Biotec, Auburn, CA). The isolation kit contains a
CD56 antibody, which in addition to NK cells, also depletes
CD56
+ T cells. Staining with surface markers routinely revealed
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+ T cells. Naı ¨ve (CD45RA
+) and memory
(CD45RO
+) T cells were negatively selected from CD4
+ T cells
either using CD45RO microbeads or CD45RA microbeads,
respectively (Miltenyi Biotec). Purity of each cell subset was
.98%. IL-18Ra
+ cells were isolated from either CD45RA
+ or
CD45RO
+ T cells by positive selection using anti-IL-18Ra-
phycoerythrin monoclonal antibody (FAB840P; R&D Systems,
Minneapolis, MN) followed by anti-PE Microbeads (Miltenyi
Biotec). All the cells, except IL-18Ra
+ cells were cultured in RPMI
1640 with 10% fetal bovine serum (FBS), 100 U/ml penicillin,
100 mg/ml streptomycin, and 2 mM glutamine. Autologous whole
blood serum (10%) instead of FBS and IL-2 (10 units/ml) were
used in culturing IL-18Ra
+ cells. Resting cells were stimulated
with 1 ng/ml of recombinant human IL-12 and/or 40 ng/ml of
recombinant human IL-18 for various periods of time. Pretreat-
ment with rapamycin and SB203580 was done 60 minutes before
IL-12/IL-18 stimulation. Splenic CD4
+ T cells were isolated from
8–12 week old mice using CD4
+ isolation kit (Miltenyi Biotec).
Murine cells were cultured in RPMI 1640 with 10% fetal bovine
serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM glutamine, 10 mM HEPES and 55 mM b-mercaptoetha-
nol. Cells were stimulated with 1 ng/ml of recombinant murine
IL-12 and/or 40 ng/ml of recombinant murine IL-18.
Mice
C57/BL6 male mice of 8–12 weeks old were used for the
experiment, and these mice were bred in the NIA animal facility
according to the protocol (423-CMS-2013) approved by the
Animal Care and Use Committee in the National Institute on
Aging at the National Institutes of Health.
Reagents
Recombinant human and murine IL-12 and murine IL-18 were
purchased from R&D Systems (Minneapolis, MN). Recombinant
human IL-18 was purchased from Medical & Biological
Laboratories Co., LTD. (Woburn, MA). Actinomycin D and
cycloheximide (CHX) were purchased from Sigma (St. Louis,
MO). PE anti-human IFN-c, FITC anti-human CD4, BD
Cytofix/Cytoperm, BD Perm/Wash, and anti-phospho Stat4
(Y693) antibody were purchased from BD Biosciences (San Jose,
CA). Anti-Stat4 antibody was purchased from Invitrogen (Carls-
bad, CA). Monensin solution was purchased from BioLegend (San
Diego, CA). Rapamycin, SB203580, cyclosporin A, IKK-2
inhibitor, SC-514, and ionomycin were purchased from Calbio-
chem (San Diego, CA).
Measurement of IFN-c production
CD4
+ T cells were stimulated for 24, 48, and 72 hours and the
supernatants were analyzed by Cytometric Beads Array (CBA) Kit
(BD Bioscience, San Diego, CA) according to the manufacturer’s
instructions.
Intracellular staining for IFN-c
CD4
+ T cells were stimulated for 48 hours with IL-12 plus IL-
18 in the presence or absence of SB203580. Approximately
18 hours before cells were harvested, monensin solution (16) was
added to stop the secretion of cytokine. Cells were collected and
washed with cold PBS. Cells were resuspended in 1 ml 10%
human serum in PBS, and were incubated for 20 min at 4uC. Cells
were collected and resuspended in 250 ml BD Cytofix/Cytoperm
solution and incubated for 20 min at 4uC. Cells were washed two
times with 1 ml BD perm/wash solution (16). Solution was
poured off, and cells were resuspended in the leftover solution.
Cells were incubated with PE anti-human IFN-c and FITC anti-
human CD4 for 30 min at 4uC in the dark. Cells were washed
twice with 1 ml BD perm/wash solution (16), and resuspended in
fixing solution before analyzing by Becton Dickinson FACSan.
Statistical analysis
For statistical analysis, p-value was calculated by Student’s t-test
using one-tail paired analysis.
Quantitative Real-time PCR
Total RNA was isolated by RNeasy Mini Kit (Qiagen, Valencia,
CA). Complementary DNA (cDNA) was synthesized from 1 mgo f
total RNA using SuperScript III reverse transcriptase kit and
random hexamers (Invitrogen, Carlsbad, CA) in a total volume of
20 ml. One-hundredth of the sample was used in a real-time PCR
reaction containing a 0.2 mM concentration of both forward and
reverse primers and iTaq SYBR Green Supermix with ROX (Bio
Rad,Hercules, CA). Quantitationof fold inductionwasanalyzed by
the 2
2DDCT method [12]. The quantity of each cDNA was
normalized by GAPDH. The following PCR primers were used for
amplification: IFN-c,5 9- TGACCAGAGCATCCAAAAGA -39
and 59-CTCTTCGACCTCGAAACAGC -39; GADD45b,5 9-
GTGTACGAGTCGGCCAAGTT-39 and 59-TTGATGTCGT
TGTCACAGCA-39; GADD45c,5 9-GGGTCCACGTTCAA-
GACTTT-39 and 59-GACACAGTTCCGGAAAGCAC-39; glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH), 59- CGAC-
CACTTTGTCAAGCTCA -39 and 59-AGGGGAGATTCAGT-
GTGGTG -39; murine IFN-c,5 9- TGAGCTCATTGAATGC-
TTGG-39 and 59-ACAGCAAGGCGAA AAAGGAT-39;a n d
murine b-actin-59- GGGGTGTTGAAGGTCTCAAA-39 and 59-
TGTTACCAACTGGGACGACA.
Results
Human peripheral blood CD4
+ T cells are responsive to
IL-12 plus IL-18 in producing IFN-c in an antigen
independent manner
IL-12 and/or IL-18 can induce production of IFN-c by
differentiated Th1 cells, which have acquired expression of both
IL-12 and IL-18 receptors. Recently, it has been shown that some
populations of resting human T cells express IL-12 receptor b1
and IL-18 receptor a [13,14]. We first examined whether IL-12
and/or IL-18 can induce production of IFN-c by resting human
peripheral blood CD4
+ T cells. Highly purified CD4
+ T cells were
stimulated with IL-12 and IL-18, either alone or in combination,
and in the presence or absence of either rapamycin, an mTOR
inhibitor, or SB203580, a p38 MAP kinase inhibitor, for 24 hours.
As shown in Figure 1A, only IL-12 plus IL-18, but not IL-12 or IL-
18 alone, induced IFN-c production by resting human peripheral
blood CD4
+ T cells. The amount of IFN-c produced by five
different donors ranged from 863.8 to 10,829.7 pg/ml after
24 hour stimulation. The production of IFN-c by IL-12 plus IL-18
was sensitive to rapamycin and SB203580, but not to cyclosporin
A (Fig. 1A & Supplemental Fig. 1A). The amount of IFN-c
produced in response to IL-12 plus IL-18 was substantially lower
(48 fold) in comparison to the total amount produced by anti-CD3
plus anti-CD28 stimulation, and this activation-induced IFN-c
production was sensitive to cyclosporin A (Fig. 1A & S1). The
activation with IL-12 and IL-18 had a synergistic effect on resting
human peripheral blood CD4
+ T cells in producing IFN-c (Fig. 1B,
and S2), and the synergism was increased with time (Fig. 1C, and
S3). Although, the cytokine stimulation of resting CD4
+ T cells
induced IFN-c production, this stimulation did not induce any
proliferation or cell death (Fig. S4).
Resting T Cell Activation by IL-12 Plus IL-18
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e18553In order to determine the percentage of resting CD4
+ T cells that
were capable of producing IFN-c upon IL-12 plus IL-18 stimulation,
purified CD4
+ T cells were activated with IL-12 plus IL-18 in the
presence or absence of SB203580 for 48 hours, and the percentage of
IFN-c T cells was determined by intracellular staining. As shown in
Fig. 1D, 0.47% of total CD4
+ T cells were IFN-c positive upon
activation, which was a 6.7-fold increase as compared to untreated
cells. This percentage decreased to the basal level in the presence of
SB203580. Among three independent donors, the highest percentage
of IFN-c positive CD4
+ T cells observed was 1.5% (Table 1). These
data indicate that a small percentage of resting CD4
+T cellsiscapable
of responding to IL-12 plus IL-18 treatment in producing IFN-c.
Effect of IL-12 plus IL-18 treatment on IFN-c mRNA level
To determine the mechanism by which IL-12 plus IL-18
treatment increases IFN-c production, human peripheral blood
CD4
+ T cells were treated with IL-12 and IL-18, either alone or in
combination, and in the presence or absence of either SB203580
or rapamycin at two different time points (1 and 24 hours). Total
Figure 1. Production of IFN-c by human peripheral blood CD4
+ T cells after activation with IL-12 plus IL-18, but not with IL-12 or IL-
18 alone. (A) Human peripheral blood CD4
+ T cells were stimulated with IL-12 (1 ng/ml) and/or IL-18 (40 ng/ml) for 24 hours in the presence or
absence of SB203580 (10 mM) and rapamycin (20 ng/ml). CD4
+ T cells were also activated with cross-linked anti-CD3 (200 ng/ml) plus anti-CD28
(0.5 mg/ml) for 24 hours. Supernatants were analyzed for IFN-c production by Cytometric Beads Array. (B) Peripheral blood CD4
+ T cells were
stimulated with the indicated concentrations of IL-12 and/or IL-18 for 24 hours and the supernatants were analyzed for IFN-c production. Results
from one representative donor out of two independent donors are shown here, and data from other donor are shown in Figure S2. (C) Peripheral
blood CD4
+ T cells were stimulated with IL-12 (1 ng/ml)/IL-18 (40 ng/ml) for various periods of times to measure IFN-c production. Results from one
representative donor out of three independent donors are shown here, and the results from other donors are shown in Figure S3. (D) Peripheral
blood CD4
+ T cells were activated with IL-12 plus IL-18 in the presence or absence of SB203580 for 48 hours, and the cells were then used for
intracellular staining for IFN-c. One representative donor among three is shown here, and the results from rest of the donors are shown in Table 1.
doi:10.1371/journal.pone.0018553.g001
Table 1. Percentage of IFN-c
+ CD4
+ T cells as determined by
intracellular staining.
Control IL-12+IL-18* IL-12+IL-18+SB**
Donor 1 0.07 0.47 0.02
Donor 2 0.05 1.5 0.07




Resting T Cell Activation by IL-12 Plus IL-18
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e18553RNAs were isolated and were analyzed for IFN-c message by real-
time PCR. As shown in Fig. 2A, IL-12 alone had some effect on
the transcription of IFN-c (4-fold induction) at the earlier time
point, whereas the combination of IL-12 and IL-18 had a
synergistic effect on the expression of IFN-c mRNA (16-fold
induction), which was partially blocked by SB203580. The
synergistic effect was further increased with time (almost 3000
fold) after 24 hours of activation. When we tested the effect of
rapamycin on the synergistic effect of IL-12 plus IL-18 treatment,
no effect was observed at the earlier time point (Fig. 2A). At the
later time point (24 hour treatment), rapamycin had a significant
suppressive effect, indicating a possible role for mTOR in IFN-c
mRNA stability. To determine whether mTOR might be involved
in regulating IFN-c mRNA at the post transcriptional level, freshly
isolated T cells were stimulated with IL-12 plus IL-18 for 18 hours
in the presence or absence of rapamycin. At 18 hours, actinomy-
cin D was added to stop new RNA synthesis, and the cultures were
incubated further for various periods of times. After each point,
total RNAs were isolated and analyzed by real-time PCR. As
shown in Fig. 2B, the rate of decay for activation-induced IFN-c
mRNA levels post actinomycin D treatment was faster in
rapamycin-pretreated samples as compared to IL-12 plus IL-18
Figure 2. Effect of cytokine treatment on IFN-c mRNA levels. (A) Human peripheral blood CD4
+ T cells were stimulated with IL-12 and/or IL-18
for either 1 hour (left panel) or 24 hours (right panel) in the presence or absence of rapamycin or SB203580. Total RNAs were isolated and analyzed
by real-time PCR. The quantity of each cDNA was normalized by GAPDH. Data represent average 6 SD from triplicate. (B) Effect of rapamycin on IL-12
plus IL-18-induced IFN-c mRNA stability. Peripheral blood CD4
+ T cells were stimulated with IL-12 plus IL-18 for 18 hours in the presence or absence
of rapamycin. At 18 hours, actinomycin D (1 mg/ml) was added to stop new RNA synthesis, and the cultures were incubated further for various
periods of times. After each point, total RNAs were isolated and analyzed by real-time PCR. The quantity of each cDNA was normalized by b-actin.
Data represent average 6 SD from triplicate.
doi:10.1371/journal.pone.0018553.g002
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results suggest that the synergistic effect of IL-12 plus IL-18
treatment on IFN-c expression is a function of both transcriptional
and post-transcriptional effects.
Synergy between IL-12 and IL-18 signaling was observed
in Stat4 phosphorylation
To investigate the signaling synergy between IL-12 and IL-18
stimulation, human peripheral blood CD4
+ T cells were
stimulated with IL-12 and IL-18, either alone or in combination,
for different periods of time. Whole cell lysates were then analyzed
for Stat4 phosphorylation by western blot analysis. As shown in
Figure 3, the synergy between IL-12 and IL-18 signaling was
observed as early as 1 hour, and the synergy was increased with
time and persisted for at least 24 hours. These data suggest a
possible mechanism underlying the requirement for both IL-12
and IL-18 stimulations in producing IFN-c.
IL-12 plus IL-18-induced IFN-c mRNA level was
independent of de novo protein synthesis, GADD45b and
GADD45c, but dependent on cRel
To investigate whether IL-12 plus IL-18-induced IFN-c
transcription requires new protein synthesis, peripheral blood
CD4
+ T cells were incubated either with or without IL-12 plus
IL-18 for 4 hours after pretreatment or no pretreatment with
cycloheximide (CHX). Total RNAs were isolated and analyzed
for IFN-c message by real-time PCR. As shown in Fig. 4, IL-12
plus IL-18-induced IFN-c transcript level was enhanced by the
pretreatment with CHX (6.8 fold), whereas CHX alone did not
have any effect. It has been reported that GADD45b plays an
important role in IL-12 plus IL-18-induced IFN-c expression in in
vitro differentiated murine Th1 cells by activating p38 MAPK
through MEKK4 [3]. In our system, we did not observe any
induction of GADD45b and GADD45c messages upon IL-12
plus IL-18 treatment, although, as reported earlier [3], CHX
pretreatment strongly induced IL-12 plus IL-18-activated
GADD45b and GADD45c messages. CHX-induced super-
induction has been reported in the case of NFkB-dependent
COX-2 transcription, which acts by inhibiting the synthesis of
IkB [15]. To determine the role of the NFkB/Rel family of
transcription factors in IL-12 plus IL-18-induced IFN-c tran-
scription, splenic CD4
+ T cells from wild type and cRel knockout
mice were activated with IL-12 plus IL-18 for 24 hours and the
IFN-c mRNA levels were determined by real-time PCR. As
shown in Fig. 4B, IL-12 plus IL-18-induced IFN-c mRNA level
was drastically reduced in cRel knockout mice, indicating an
involvement of cRel in IL-12 plus IL-18-induced IFN-c
transcription. Next, we wanted to investigate whether NFkB/
Rel family transcription factors were also involved in IL-12 plus
IL-18-induced IFN-c transcription in human CD4
+ T cells. We
used IKK-2 inhibitor to block NFkB-mediated gene transcription
[16]. As shown in Fig. 4C, IL-12 plus IL-18-induced IFN-c
mRNA level was decreased by IKK-2 inhibitor in a dose-
dependent manner, indicating that the NFkB/Rel family
transcription factors also play an important role in IL-12 plus
IL-18-induced IFN-c transcription in human CD4
+ T cells.
Collectively, these data suggest the following: first, in resting
human peripheral blood CD4
+ T cells, IL-12 plus IL-18-induced
IFN-c expression is not dependent on new protein synthesis;
second, GADD45b and GADD45c do not appear to play any
role in IL-12 plus IL-18-mediated IFN-c mRNA expression; and
third, NFkB/Rel family transcription factors play an important
role in IL-12 plus IL-18-induced IFN-c expression.
Naı ¨ve CD4
+ T cells, as well as the memory population,
respond to IL-12 plus IL-18 in producing IFN-c
To investigate whether the responsiveness of CD4
+ T cells to
IL-12 plus IL-18 treatment was unique to either naı ¨ve or memory
populations, naı ¨ve (CD45RA
+) and memory (CD45RO
+) cells
were purified from resting CD4
+ T cells by negative selection, and
were activated with IL-12 plus IL-18 in the presence or absence of
SB203580. Interestingly, both naı ¨ve and memory populations
were capable of responding to IL-12 plus IL-18 in producing IFN-
c, and as expected, memory populations produced higher amounts
of IFN-c than naı ¨ve populations (for three donors ranged from 318
to 1907 pg/ml for naı ¨ve, and 1272 to 9368 pg/ml for memory
populations, Fig. 5A).
To isolate the CD4
+ populations responsive to IL-12 plus IL-18,
we purified IL-18Ra
+ cells from both naı ¨ve and memory CD4
+
populations, since this is the receptor chain among others (IL-
18Rb, IL-12Rb1 and IL-12Rb2) that has the highest expression
levels on resting T cells (data not shown). Isolated IL-18Ra
+ CD4
+
T cells were treated with IL-12 plus IL-18 for 48 hours in the
presence or absence of SB203580, and the supernatants were
assayed for IFN-c. As shown in Fig. 5B, IL-18Ra
+ CD4
+ T cells
from both naı ¨ve and memory populations produced IFN-c upon
IL-12 plus IL-18 stimulation, and the activation-induced IFN-c
production was blocked by the p38 MAP kinase inhibitor. The
amount of IFN-c produced by five different donors ranged from
443 to 4274 pg/ml for naı ¨ve, and 1,591 to 26,496 pg/ml for
memory populations.
To determine the percentage of naı ¨ve and memory IL-18Ra
+
CD4
+ T cells that were capable of producing IFN-c upon IL-12
plus IL-18 stimulation, purified IL-18Ra
+ CD4
+ T cells from
naı ¨ve (RA
+18
+) and memory (RO
+18
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activated with IL-12 plus IL-18 in the presence or absence of
SB203580 for 48 hours, and the percentage of IFN-c
+ CD4
+ T
cells was determined by intracellular staining. As shown in
Fig. 5C, 2.6% of naı ¨ve IL-18Ra
+ CD4
+ T cells and 20.5% of
memory IL-18Ra
+ CD4
+ Tw e r eI F N - c positive upon activation,
and these percentages decreased to the basal level in the presence
of SB203580. Moreover, activation-induced IFN-c
+ cells were
mainly obtained from IL-18Ra
+ CD4
+ T cells. The percentage of
IFN-c
+ cells obtained from three independent donors ranged
from 1.5 to 2.6% for naı ¨ve population (Table 2), and 15 to 20%
for memory population (Table 3). These data indicated that a
subset of naı ¨ve CD4
+ T cells are unique in responding
synergistically to IL-12 plus IL-18 stimulation in producing
IFN-c.
Figure 3. Synergistic effect of IL-12 plus IL-18 treatment on
Stat4 phosphorylation. Human peripheral blood CD4
+ T cells were
treated with IL-12 and IL-18, either alone or in combination, for different
periods of time. Equal amounts of whole cell lysates (35 mg) were
analyzed by western blot analysis.
doi:10.1371/journal.pone.0018553.g003
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In this report we have shown that a subset of human peripheral
blood CD4
+ T cells can be activated with the combination of IL-
12 plus IL-18, but not by either IL-12 or IL-18 alone, to produce
IFN-c in the absence of any antigenic stimulation. A small
percentage of resting human peripheral blood CD4
+ T cells (0.5 to
1.5%) was responsive to IL-12 plus IL-18. Interestingly, both naı ¨ve
(CD45RA




+ responded to IL-12 plus IL-18 stimulation in
producing IFN-c. The capacity of cytokines to elicit IFN-c
production from resting naı ¨ve T cells in an antigen independent
fashion indicates a possible role for T cells in innate immunity.
It has been reported previously that IL-12 plus IL-18-induced
IFN-c transcription by in vitro differentiated murine Th1 cells
requires new protein synthesis and is dependent on GADD45b
[3]. In resting human peripheral blood CD4
+ T cells on the
contrary, we show that cycloheximide pretreatment increased IL-
12 plus IL-18-induced IFN-c transcription indicating that new
protein synthesis was not required for IL-12 plus IL-18-induced
IFN-c transcription by resting human CD4
+ T cells. In agreement
with this conclusion, IL-12 plus IL-18-induced IFN-c transcription
by resting human CD4
+ T cells was independent of GADD45b
and GADD45c. This was not due to technical limitations, since, as
reported earlier [3], cycloheximide pretreatment strongly induced
IL-12 plus IL-18-induced GADD45b and GADD45c messages.
These results are in apparent contradiction with the results
reported by Yang et al. [3]. The reason for the discrepancies may
be due to the fact that Yang et al. have used in vitro differentiated
murine Th1 cells, whereas freshly isolated human peripheral blood
T cells were used in our study. It is important to note that in spite
of the apparent lack of GADD45b involvement in human CD4
+ T
cells, like the murine system [3], IL-12 plus IL-18-induced IFN-c
production by human CD4
+ T cells was dependent on p38 MAP
kinase. This indicates that the activation of p38 MAP kinase by IL-
12 plus IL-18 in human CD4
+ T cells involves a GADD45b-
independent pathway. We have also shown here that cRel, an
NFkB/Rel family transcription factor, plays an important role in
IL-12 plus IL-18-induced IFN-c transcription. Regarding the
signaling mechanism, we have observed a synergy between IL-12
and IL-18 stimulation with regards to Stat4 phosphorylation. The
signaling synergy was observed as early as 1 hour, which reached
the peak by 6 hours, and persisted for at least 24 hours. More in-
depth signaling mechanisms involved in the IL-12 plus IL-18-
mediated IFN-c production by naı ¨ve human peripheral blood T
cells is currently under investigation.
The in vivo physiological role of IL-12 plus IL-18-mediated
IFN-c production by naı ¨ve CD4
+ T cells in the absence of
antigen is not known. This pathway may play an important role
in innate immunity as a rapid responder to pathogens in the
absence of cognate antigen recognition. In accordance with this
hypothesis, Berg et al., have shown a contribution of memory
murine CD8
+ T cells to innate immunity in protection against
Listeria monocytogenes in the absence of cognate antigen by rapidly
Figure 4. Effect of cytokine treatment on the mRNA levels of IFN-c, GADD45b and GADD45-c. (A) Human peripheral blood CD4
+ T cells
were pre-treated with cyclohexamide (10 mg/ml) for 30 minutes followed by stimulation with IL-12 and IL-18 for 4 hours. Total RNAs were isolated
and analyzed by real-time PCR. The quantity of each cDNA was normalized by GAPDH. Data represent average 6 SD from triplicate. (B) Role of cRel in
cytokine signaling. Splenic CD4
+ T cells from wild type and cRel knockout mice were activated with IL-12 plus IL-18 for 24 hours and the IFN-c mRNA
levels were determined by real-time PCR. The quantity of each cDNA was normalized by GAPDH. Data represent average 6 SD from triplicate. (C) Role
of NFkB/Rel family transcription factors in cytokine signaling in human CD4
+ T cells. Human CD4
+ T cells were pretreated with IKK-2 inhibitor (50 and
100 mM) for 1 hour before activating the cells with IL-12 plus IL-18 for 18 hours. IFN-c mRNA levels were then determined by real-time PCR. The
quantity of each cDNA was normalized by GAPDH.
doi:10.1371/journal.pone.0018553.g004
Resting T Cell Activation by IL-12 Plus IL-18
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CD8
+ memory T cell subsets have also been shown to respond
vigorously to IL-12 plus IL-18 in the presence of IL-15 by
producing IFN-c [18]. Recently, it has been shown that a subset
of resting human effector-memory T helper cells can be induced
to produce IFN-c by IL-12 plus IL-18 in conjunction with
cytokines signaling via the IL-2R common c-chain, and the
authors have provided rationale for the involvement of effector-
memory T helper cells in chronic autoimmune inflammation
[19]. The antigen-independent cytokine-mediated pathway of
Figure 5. Production of IFN-c by the sub-population of resting human peripheral blood CD4
+ T cells after activation with IL-12 plus
IL-18. (A) Naı ¨ve (RA
+) and memory (RO
+) cells isolated from human peripheral blood CD4
+ T cells were stimulated with IL-12 and IL-18 for 48 hours in
the presence or absence of SB203580. Supernatants were analyzed for IFN-c production. (B) Responsiveness of IL-18Ra
+ T cells to IL-12 plus IL-18.
Freshly isolated IL-18Ra
+ T cells from naı ¨ve (RA
+18
+) and memory (RO
+18
+) CD4
+ T cells were treated with IL-12 plus IL-18 for 48 hours in the presence
or absence of SB203580. Supernatants were analyzed for IFN-c production. (C) IL-18Ra
+ (upper panel, 18
+) and IL-18Ra
2 (lower panel, 18
2) T cells
from naı ¨ve (CD4
+RA
+) and memory (CD4
+ RO
+) T cells were treated with IL-12 plus IL-18 for 48 hours in the presence or absence of SB203580, and the
cells were then used for intracellular staining for IFN-c. One representative donor among three is shown here, and data from rest of the donors are
shown in Tables 2 & 3.
doi:10.1371/journal.pone.0018553.g005
Table 2. Percentage of IFN-c




cells as determined by intracellular staining.
Control IL-12+IL-18* IL-12+IL-18+SB**
Donor 1 1 2.6 1.1
Donor 2 1.1 1.5 1




Table 3. Percentage of IFN-c




cells as determined by intracellular staining.
Control IL-12+IL-18* IL-12+IL-18+SB**
Donor 1 2.4 20.5 3.4
Donor 2 2 15 3.1
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pathological conditions [20]. It has been shown that TL1A (TNF-
like cytokine) synergizes with IL-12 plus IL-18 in inducing IFN-c
by CD4
+ T cells [21,22], and TL1A production by immune
complex-stimulated monocytes may be involved in the patho-
genesis of rheumatoid arthritis [23]. This cell subset may also be
involved in amplifying an antigen-driven T cell immune response
in that IL-12 and IL-18 are both produced in the course of such
T-cell receptor-driven processes. Since we have shown here that
the cytokine-induced pathway for IFN-c production is blocked by
rapamycin, mTOR may be a therapeutic target in the treatment
of autoimmune diseases characterized by IFN-c overexpression.
The existence of a pathway of naı ¨ve T cell activation in the
absence of antigen may play a role in a wide range of
immunological conditions.
Supporting Information
Figure S1 Human peripheral blood CD4
+ T cells from
two independent donors were activated with either anti-
CD3 plus anti-CD28 or IL-12 plus IL-18 in the presence
or absence of cyclosporin A for 24 hours and the
supernatants were analyzed for IFN-c production. Results
from two independent donors are shown here.
(TIF)
Figure S2 Freshly isolated human peripheral blood
CD4
+ T cells were stimulated with the indicated
concentrations of IL-12/or IL-18 for 24 hours and the
supernatants were analyzed for IFN-c production.
(TIF)
Figure S3 Freshly isolated human peripheral blood
CD4
+ T cells from two independent donors were
stimulated with IL-12 (1 ng/ml)/IL-18 (40 ng/ml) for
various periods of times to measure IFN-c production.
(TIF)
Figure S4 Freshly isolated human peripheral blood
CD4
+ T cells from two independent donors were
cultured either in the medium alone or in the presence
of IL-12 plus IL-18 for various periods of times. At each
time point, cell viability was determined by trypan blue staining,
and cell numbers were determined by cell count.
(TIF)
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